Navigation Links
Dwayne Johnson, Novo Nordisk and the Entertainment Industry Foundation Educate Families about Healthy Living and Diabetes
Date:8/12/2009

PRINCETON, N.J. and LOS ANGELES, Aug. 12 /PRNewswire/ -- Dwayne Johnson joins with Novo Nordisk, a world-leader in diabetes care, and the Entertainment Industry Foundation (EIF), a leading charitable organization of the entertainment industry, to encourage families to get active together as a means to help prevent diabetes. As an ambassador for the Diabetes Aware campaign, Johnson will appear in a public service announcement (PSA) to educate families about the prevalence of diabetes and the importance of an active, healthy lifestyle.

The PSA is part of the ongoing Diabetes Aware educational campaign sponsored by Novo Nordisk and the EIF. The campaign aims to reach the 24 million Americans who are living with diabetes, as well as the estimated 6.2 million Americans who are unaware that they have the disease, to underline the importance of detection, monitoring and proper management of diabetes.

A lifelong athlete and known for starring in family-friendly movies, Johnson recognizes the value of a healthy lifestyle in helping to prevent and manage diabetes for both children and adults. "I'm honored to serve as an ambassador to the Diabetes Aware campaign, and I want to encourage families to be active and eat right," said Johnson. "Small steps can go a long way in managing diabetes, its complications, and raising healthy, active children."

With the launch of this new PSA, Johnson becomes the latest celebrity ambassador to join the Diabetes Aware program since its inception in 2004. Past ambassadors include Halle Berry, Cuba Gooding, Jr., Dustin Hoffman, Kevin Kline and Jon Lovitz among others.

"We are delighted to continue our partnership with the Entertainment Industry Foundation and believe Dwayne Johnson is a great ambassador for the Diabetes Aware program based on his dedication to reaching families, both on-screen and off-screen," said Andrew Purcell, Vice-President of Strategic Business Development at Novo Nordisk. "This partnership truly exemplifies Novo Nordisk's dedication to prevention and ultimately changing diabetes."

For additional free patient education resources, visit www.ChangingDiabetes-us.com.

About Diabetes

Diabetes is a disease in which the body does not produce or properly use insulin. Insulin is a hormone that is needed to convert sugar, starches and other food into energy needed for daily life. The cause of diabetes continues to be a mystery, although both genetics and environmental factors such as obesity and lack of exercise appear to play roles.

About Novo Nordisk

Novo Nordisk is a healthcare company with an 86-year history of innovation and achievement in diabetes care. The company has the broadest diabetes product portfolio in the industry, including the most advanced products within the area of insulin delivery systems. In addition to diabetes care, Novo Nordisk has a leading position within areas such as hemostasis management, growth hormone therapy, and hormone therapy for women. Novo Nordisk's business is driven by the Triple Bottom Line: a commitment to social responsibility to employees and customers, environmental soundness and economic success. With headquarters in Denmark, Novo Nordisk employs more than 27,000 employees in 81 countries, and markets its products in 179 countries. Novo Nordisk's B shares are listed on the stock exchanges in Copenhagen and London. Its ADRs are listed on the New York Stock Exchange under the symbol 'NVO.' For global information, visit novonordisk.com; for United States information, visit novonordisk-us.com.

Entertainment Industry Foundation

The Entertainment Industry Foundation, as a leading charity of the entertainment industry, has distributed hundreds of millions of dollars -- and provided countless hours -- to support charitable initiatives that address some of the most critical issues facing our society.


'/>"/>
SOURCE Novo Nordisk
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Beacon Equity Researches: Sanofi-Aventis, Amazon, Yahoo, Johnson & Johnson, Novavax and NexMed
2. SearchAmerica(R) President, Daniel Johnson, Named Ernst & Young Entrepreneur Of The Year(R)
3. Now Playing: Spike Lee Stands with Earvin Magic Johnson, Cookie Johnson and Abbott to Launch National PSA Campaign
4. AHCA, Alliance Praise Bipartisan Johnson, Collins Letter Urging Rejection of Bush Medicare Cuts
5. UAN Mourns Passing of President Cheryl L. Johnson, RN
6. Novo Nordisk Appoints Per Falk, M.D., Ph.D., as Vice President for Clinical, Medical and Regulatory Affairs for North America
7. Novo Nordisk Launches Twitter Page with Race Car Driver Charlie Kimball
8. Novo Nordisk Insulin Analogs Have Proven Safety Profiles
9. Novo Nordisk Warns Customers About Stolen Insulin
10. Diabetes Experts Partner With Novo Nordisk to Provide New Patient Materials
11. Photos: Novo Nordisk Improved FlexPen(R) Now Available in the U.S.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/25/2016)... ... June 25, 2016 , ... On Friday, June 10, ... Bronze Wellness at Work award to iHire in recognition of their exemplary accomplishments in ... the 7th annual Maryland Workplace Health & Wellness Symposium at the BWI Marriott in ...
(Date:6/24/2016)... ... ... June 19, 2016 is World Sickle Cell Observance Day. In an effort ... holistic treatments, Serenity Recovery Center of Marne, Michigan, has issued a pain ... Disease (SCD) is a disorder of the red blood cells, which can cause episodes ...
(Date:6/24/2016)... ... 24, 2016 , ... Dr. Amanda Cheng, an orthodontist ... has extensive experience with all areas of orthodontics, including robotic Suresmile technology, ... , Micro-osteoperforation is a revolutionary adjunct to orthodontic treatment. It can be used ...
(Date:6/24/2016)... ... June 24, 2016 , ... EB Medicine ... Making in Emergency Medicine conference in Ponte Vedra Beach, FL. The awards honor ... Emergency Medicine Practice and Pediatric Emergency Medicine Practice. , “With this ...
(Date:6/24/2016)... ... 24, 2016 , ... National recruitment firm Slone Partners is pleased ... and genomics experience, as Vice President of North American Capital Sales at HTG ... leading the sales team in the commercialization of the HTG EdgeSeq system and associated ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... , June 24, 2016  Global Blood ... biopharmaceutical company developing novel therapeutics for the treatment ... today announced the closing of its previously announced ... stock, at the public offering price of $18.75 ... offering were offered by GBT. GBT estimates net ...
(Date:6/24/2016)... June 24, 2016 ... announced the addition of the " Global Markets ... This report focuses ... an updated review, including its applications in various applications. ... market, which includes three main industries: pharmaceutical and biotechnology, ...
(Date:6/24/2016)... , June 24, 2016 The Academy ... of recommendations that would allow biopharmaceutical companies ... with entities that make formulary and coverage decisions, a ... "value" of new medicines. The recommendations address ... not appear on the drug label, a prohibition that ...
Breaking Medicine Technology: